GGrantIndex
← Search

Community Outreach and Engagement

$75,115P30FY2022CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

ABSTRACT The overarching goal of the University of Chicago Medicine Comprehensive Cancer Center (UCCCC) Community Outreach and Engagement Component is to improve the prevention, detection, and treatment of cancer, as well as advance progress in cancer survivorship, particularly as relevant to disparities in our catchment area. Our catchment area is defined as 10 counties surrounding the University of Chicago, 81% of our cancer patients reside in our catchment area. The area has a sizeable population of underrepresented minorities with 53% non-Hispanic White, 17% non-Hispanic African American, 6% Asian, and 22% Hispanic. Cancer-related characteristics of our catchment area include: a) increased incidence and/or mortality of lung, breast, prostate, cervical, and colorectal cancers compared to the US; b) a larger Black/White difference in mortality from cancer compared to the US; c) higher rates of “at-risk” behaviors, including smoking and obesity; d) and lower rates of colorectal cancer screening. The UCCCC has extensive basic, clinical, translational, and population sciences research addressing these elevated cancer rates and risk factors at multiple levels, including research aimed at: a) defining the cancer problems and disparities in the catchment area, in particular through two large cohort studies; 2) understanding the cancer problems and disparities in the catchment area (e.g., through research focusing on interethnic and interracial differences in genetics, basic biology, and chemotherapy side effects); 3) intervening to improve cancer problems and disparities in the catchment area (e.g., smoking cessation and colorectal cancer screening); and 4) research beyond the catchment area, particularly in global health. We have also identified a 13-zipcode area in our catchment area, directly surrounding the UCCCC, which suffers disproportionate cancer burdens, and we are conducting additional targeted research and outreach in these communities. The UCCCC Office of Community Engagement and Cancer Disparities (OCECD) directed by Karen Kim, MD, UCCCC Associate Director for Community Engagement and Cancer Disparities, serves as a bridge between the UCCCC and community stakeholders to promote collaboration and to address cancer disparities at multiple levels. The OCECD plays a critical role in centralizing the UCCCC’s activities in outreach and engagement, and fostering the conduct of research relevant to our catchment area in each of the Research Programs. Over the next funding period, we will extend successful programs into prostate cancer, increase our focus on cancer disparities in Hispanic communities, and continue to expand access to our clinical trials through new University of Chicago Medicine (UCM) network affiliates.

View original record on NIH RePORTER →